fig2

Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance

Figure 2. Mechanisms by which HIF-1 regulates immune checkpoint molecules and immune evasion [reproduced with permission from You et al. (2021)[98]. Copyright 2020 John Wiley and Sons]. HIF-1: Hypoxia-inducible factor-1.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/